Primary lymphoma of the cervix uteri: A diagnostic challenge. Report of two cases and review of the literature

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Ghent University Hospital, Belgium.
European journal of gynaecological oncology (Impact Factor: 0.61). 02/2005; 26(1):36-8.
Source: PubMed


Primary non Hodgkin's lymphoma (NHL) of the cervix and vagina is uncommon; the incidence of uterine lymphoma is estimated to be less than 0.5% of all NHL. Patients regularly present with vaginal bleeding. The diagnosis is made on biopsy but this can be difficult on small samples which may not be representative of the lesion. Immunohistochemical analysis and often molecular techniques are required to confirm the diagnosis.
We report two cases of primary diffuse large B-cell lymphoma of the cervix. In the first case, the diagnosis could only be made on repeat biopsies. The second case presented as a cervical polyp.
Gynecologists should be aware of this rare clinical entity in order to apply the proper treatment.

1 Follower
6 Reads
  • Source
    • "If the base is visualized, then cauterization should be performed to prevent further bleeding. All polyps that are removed should be sent to pathology to be evaluated for malignancy [52–54]. Furthermore, if there is concern for endometrial polyps, then the patient should be referred to operative hysteroscopy with possible dilation and curettage. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Postcoital bleeding refers to spotting or bleeding that occurs after intercourse and is not related to menstruation. The prevalence of postcoital bleeding ranges from 0.7 to 9.0 percent of menstruating women. There are multiple etiologies for this common complaint in which most are benign such as cervicitis or cervical polyps. However, the most serious cause of postcoital bleeding is cervical cancer. There are currently no recommendations from governing bodies such as the American College of Obstetricians and Gynecologists on evaluating and treating women with postcoital bleeding. The purpose of this paper is to discuss the common causes of postcoital bleeding, the etiologies of postcoital bleeding, and the likelihood that malignancy is the underlying cause. After an extensive literature review, we compiled a paper illustrating the key concepts a practitioner should know when it comes to postcoital bleeding. Finally, this review will conclude with treatment options for women who are found to have an identifiable source for their bleeding and a discussion on the natural history of postcoital bleeding in women who are found to have no identifiable etiology on evaluation.
    Obstetrics and Gynecology International 06/2014; 2014:192087. DOI:10.1155/2014/192087
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lymphoma-like lesion of the uterine cervix is a benign reactive lymphoid hyperplasia associated with chronic cervicitis that may pose a problem in differential diagnosis from malignant lymphoma. It is a rare entity and only about 20 cases have been reported in the world literature. Two cases of cervical lymphoma-like lesion are described. In both patients, the diagnosis was based on microscopic examination of biopsies taken from the uterine cervix. One patient subsequently had a cervical conization that confirmed the diagnosis of lymphoma-like lesion. Both patients are well, alive and with no evidence of malignant lymphoma. It is concluded that the diagnosis of lymphoma-like lesion is based on the well-established characteristic microscopic features of this lesion. Immunohistochemical staining is usually not helpful in distinguishing this lesion from malignant lymphoma. No specific treatment is necessary for this condition.
    Zhonghua bing li xue za zhi Chinese journal of pathology 01/2006; 34(12):821-2. DOI:10.1097/01.pgp.0000228144.59677.5a
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary malignant lymphoma occurring in the uterine cervix is a rare event. We report a case of primary non-Hodgkin's lymphoma of the uterine cervix mimicking leiomyoma. The immunophenotype of the tumor and the differential diagnostic approach to this uncommon malignancy also are presented.
    Pathology - Research and Practice 02/2006; 202(1):61-4. DOI:10.1016/j.prp.2005.10.009 · 1.40 Impact Factor
Show more